[Ru(bpy)2(5-cyanouracil)2]2+ as a potential light-activated dual-action therapeutic agent.
about
Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium CompoundPhotoinduced intercalation and coordination of a dirhodium complex to DNA: dual DNA binding.Light activation of a cysteine protease inhibitor: caging of a peptidomimetic nitrile with Ru(II)(bpy)2Inhibition of cathepsin activity in a cell-based assay by a light-activated ruthenium compound.Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapySolid-phase synthesis as a platform for the discovery of new ruthenium complexes for efficient release of photocaged ligands with visible light.Ruthenium-Caged Antisense Morpholinos for Regulating Gene Expression in Zebrafish Embryos.Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complexPhotochemistry of RuII 4,4'-bi-1,2,3-triazolyl (btz) complexes: crystallographic characterization of the photoreactive ligand-loss intermediate trans-[Ru(bpy)(κ2-btz)(κ1-btz)(NCMe)]2+Influence of the Steric Bulk and Solvent on the Photoreactivity of Ruthenium Polypyridyl Complexes Coordinated to l-Proline.Selective Photodissociation of Acetonitrile Ligands in Ruthenium Polypyridyl Complexes Studied by Density Functional Theory.A new class of Ru(II) polyazine agents with potential for photodynamic therapyEffects of Methyl Substitution in Ruthenium Tris(2-pyridylmethyl)amine Photocaging Groups for Nitriles.Ultrafast in cellulo photoinduced dynamics processes of the paradigm molecular light switch [Ru(bpy)2dppz](2.).Ruthenium tris(2-pyridylmethyl)amine as an effective photocaging group for nitriles.Quantum dot photosensitizers. Interactions with transition metal centers.Photoactivatable metal complexes: from theory to applications in biotechnology and medicine.Caged oligonucleotides for studying biological systems.Rapid generation of HNO induced by visible light.Phototoxicity of strained Ru(ii) complexes: is it the metal complex or the dissociating ligand?Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation.Fine control on the photochemical and photobiological properties of Ru(II) arene complexes.An Overview Of Photosubstitution Reactions Of Ru(II) Imine Complexes And Their Application In Photobiology And Photodynamic Therapy.Cytotoxicity of cyclometallated ruthenium complexes: the role of ligand exchange on the activity.Ruthenium polypyridyl phototriggers: from beginnings to perspectives.A Visible-Light-Sensitive Caged SerotoninKinetics and Photochemistry of Ruthenium Bisbipyridine Diacetonitrile Complexes: An Interdisciplinary Inorganic and Physical Chemistry Laboratory Exercise.Isomerization initiated by photoinduced ligand dissociation in Ru(II) complexes with the ligand 2-p-tolylpyridinecarboxaldimine.BODIPY-modified Ru(II) arene complex--a new ligand dissociation mechanism and a novel strategy to red shift the photoactivation wavelength of anticancer metallodrugs.Photochemical and Photobiological Activity of Ru(II) Homoleptic and Heteroleptic Complexes Containing Methylated Bipyridyl-type Ligands.To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal.The cis-Diammineplatinum(II) Complex of Curcumin: A Dual Action DNA Crosslinking and Photochemotherapeutic Agent.Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1.Labilizing the Photoinert: Extraordinarily Facile Photochemical Ligand Ejection in an [Os(N^N)3 ](2+) Complex.Effects of the Bidentate Ligand on the Photophysical Properties, Cellular Uptake, and (Photo)cytotoxicity of Glycoconjugates Based on the [Ru(tpy)(NN)(L)]2+ Scaffold.Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go?Ru(ii) polypyridyl complexes as photocages for bioactive compounds containing nitriles and aromatic heterocycles.New cyclometallated Ru(II) complex for potential application in photochemotherapy?Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery.Substituent effect and wavelength dependence of the photoinduced Ru-O homolysis in the [Ru(bpy)2(py-SO3)](+)-type complexes.
P2860
Q28550925-BF1AD921-6E6E-40DB-8E56-6FB11887D73BQ30806098-503323DD-E83A-4BD9-9230-1E8448B32D45Q33635076-37FDDC28-D35D-4C43-8A45-7A9A9589F886Q33893128-23A5AB17-9D3A-448F-A6C7-78FBD8C07B06Q35128594-DF8D7593-1514-4466-A22C-B6DD49CDDE56Q35547191-8999AEE2-31C4-41E5-8F2F-5A3A5E5779D8Q35647158-AFF673B3-9873-4F3A-BA9A-FA6D08C1F5C9Q35805471-29178441-6E9A-44CB-8B0E-81D57FD07804Q35863531-4148727E-A535-4DFA-A2AF-81EC7ADADB86Q36345759-9930769C-ED31-4F17-84EA-BCDEB8DACA84Q36549488-A99F67A9-7702-4DC0-9E27-D87B6A7FE00CQ36761246-29D7F86E-93C2-4006-A9F3-C27CDA9BC129Q37138342-45FC6D4E-FF26-49B6-9734-DDFCF6402F02Q37267323-3B65C3AC-E3A9-4D12-A7F1-8335FD384F45Q37714170-E0CD9553-FA92-410F-A400-72C19AD37BC2Q38046074-F159A07F-5448-4DC6-A8DA-1F4EB8F93D10Q38115294-C2F87F01-6434-4770-8CFC-314B3DA3D1A8Q38416896-1FCC679B-17B6-47FA-88AA-0CBE7C52509BQ38690417-3C10A95E-23A7-4B14-8FCA-5B2ADD31D3BCQ38696298-DC16E90A-7E4C-43EC-A87F-A3FD1FE960B7Q38791247-07517D7A-E65A-455A-93DC-FED3591E5EFDQ38896587-1FCD5D68-8B7B-4715-B5B2-06129441B1FCQ39064315-407B96AE-4A9A-48A1-BD0A-A07FFDA41111Q39138126-558B01A2-770F-4F4B-B5A1-DA4514337F33Q39400764-A2869933-1762-4A9D-914C-0CDBA810FB21Q41536076-C528FADF-0413-485D-BB66-A9A1AF6E17F7Q42986388-07A92183-1C21-4D61-9A32-91B3940C6DBDQ43429163-3A53474D-F86F-481F-93AE-2F23E809629DQ45829231-0ADCAB7D-B49F-4BE7-BF90-178BBDA7515DQ46300487-BC1EE2C8-C2D3-4658-BB0E-D4F1E1896CEEQ46353606-7CDC3738-35B5-420B-A6F9-BF79E2166D98Q46662167-0C6AAE96-4E4D-4C6F-9BDA-12334A8B1D8DQ48044713-4FA47568-CBB0-464F-A205-F15A3DF49AE9Q48130082-20817E15-DDFC-420B-A4FF-D7E7EA147A6BQ48151913-7623A414-7174-4456-AB86-95417C736F8CQ48349431-A34A19F7-D493-49BB-9F05-85E532F98EA5Q50091548-3BDF8068-A592-45A5-BCAB-012ED579DD87Q50483545-0534FD8D-07C9-4A7A-A4D4-FB4CF436FF4BQ50803523-6791FE9B-898F-4CA0-A85D-99338735EC40Q52889718-D22DE855-133D-4EBC-A71F-BFC5F2981E13
P2860
[Ru(bpy)2(5-cyanouracil)2]2+ as a potential light-activated dual-action therapeutic agent.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
[Ru(bpy)2(5-cyanouracil)2]2+ a ...... dual-action therapeutic agent.
@ast
[Ru(bpy)2(5-cyanouracil)2]2+ a ...... dual-action therapeutic agent.
@en
type
label
[Ru(bpy)2(5-cyanouracil)2]2+ a ...... dual-action therapeutic agent.
@ast
[Ru(bpy)2(5-cyanouracil)2]2+ a ...... dual-action therapeutic agent.
@en
prefLabel
[Ru(bpy)2(5-cyanouracil)2]2+ a ...... dual-action therapeutic agent.
@ast
[Ru(bpy)2(5-cyanouracil)2]2+ a ...... dual-action therapeutic agent.
@en
P2093
P2860
P356
P1433
P1476
[Ru(bpy)2(5-cyanouracil)2]2+ a ...... dual-action therapeutic agent.
@en
P2093
Claudia Turro
Judith C Gallucci
Kim R Dunbar
Robert N Garner
P2860
P304
P356
10.1021/IC201615U
P407
P577
2011-08-31T00:00:00Z